Pimavanserin, a selective 5-HT2A antagonist/inverse agonist, reverse psychosis-like behaviors, suggesting that 5HT2A antagonism/inverse agonism may treat psychosis in PD. The gene discussed is HTR2A; the disease is Parkinson disease.